Literature DB >> 28344008

The time has come: sparing injectables in paediatric MDR-TB.

Ethel D Weld1, Anthony J Garcia-Prats2, Jennifer J Furin3, Theodore C Bailey4, Anneke C Hesseling2, Kelly E Dooley5.   

Abstract

Entities:  

Year:  2017        PMID: 28344008      PMCID: PMC9181438          DOI: 10.1016/S2213-2600(17)30078-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   102.642


× No keyword cloud information.
  12 in total

1.  The early bactericidal activity of amikacin in pulmonary tuberculosis.

Authors:  P R Donald; F A Sirgel; A Venter; E Smit; D P Parkin; B W Van de Wal; D A Mitchison
Journal:  Int J Tuberc Lung Dis       Date:  2001-06       Impact factor: 2.373

2.  Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.

Authors:  A H Diacon; R Dawson; M Hanekom; K Narunsky; A Venter; N Hittel; L J Geiter; C D Wells; A J Paccaly; P R Donald
Journal:  Int J Tuberc Lung Dis       Date:  2011-07       Impact factor: 2.373

3.  Delamanid for multidrug-resistant pulmonary tuberculosis.

Authors:  Maria Tarcela Gler; Vija Skripconoka; Epifanio Sanchez-Garavito; Heping Xiao; Jose L Cabrera-Rivero; Dante E Vargas-Vasquez; Mengqiu Gao; Mohamed Awad; Seung-Kyu Park; Tae Sun Shim; Gee Young Suh; Manfred Danilovits; Hideo Ogata; Anu Kurve; Joon Chang; Katsuhiro Suzuki; Thelma Tupasi; Won-Jung Koh; Barbara Seaworth; Lawrence J Geiter; Charles D Wells
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

4.  Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration.

Authors:  A R Beaubien; E Ormsby; A Bayne; K Carrier; G Crossfield; M Downes; R Henri; M Hodgen
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs.

Authors:  P Tran Ba Huy; P Bernard; J Schacht
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.

Authors:  Makoto Matsumoto; Hiroyuki Hashizume; Tatsuo Tomishige; Masanori Kawasaki; Hidetsugu Tsubouchi; Hirofumi Sasaki; Yoshihiko Shimokawa; Makoto Komatsu
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study.

Authors:  James A Seddon; Anneke C Hesseling; Peter Godfrey-Faussett; H Simon Schaaf
Journal:  Thorax       Date:  2013-09-24       Impact factor: 9.139

8.  Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Authors:  Shama D Ahuja; David Ashkin; Monika Avendano; Rita Banerjee; Melissa Bauer; Jamie N Bayona; Mercedes C Becerra; Andrea Benedetti; Marcos Burgos; Rosella Centis; Eward D Chan; Chen-Yuan Chiang; Helen Cox; Lia D'Ambrosio; Kathy DeRiemer; Nguyen Huy Dung; Donald Enarson; Dennis Falzon; Katherine Flanagan; Jennifer Flood; Maria L Garcia-Garcia; Neel Gandhi; Reuben M Granich; Maria G Hollm-Delgado; Timothy H Holtz; Michael D Iseman; Leah G Jarlsberg; Salmaan Keshavjee; Hye-Ryoun Kim; Won-Jung Koh; Joey Lancaster; Christophe Lange; Wiel C M de Lange; Vaira Leimane; Chi Chiu Leung; Jiehui Li; Dick Menzies; Giovanni B Migliori; Sergey P Mishustin; Carole D Mitnick; Masa Narita; Philly O'Riordan; Madhukar Pai; Domingo Palmero; Seung-kyu Park; Geoffrey Pasvol; Jose Peña; Carlos Pérez-Guzmán; Maria I D Quelapio; Alfredo Ponce-de-Leon; Vija Riekstina; Jerome Robert; Sarah Royce; H Simon Schaaf; Kwonjune J Seung; Lena Shah; Tae Sun Shim; Sonya S Shin; Yuji Shiraishi; José Sifuentes-Osornio; Giovanni Sotgiu; Matthew J Strand; Payam Tabarsi; Thelma E Tupasi; Robert van Altena; Martie Van der Walt; Tjip S Van der Werf; Mario H Vargas; Pirett Viiklepp; Janice Westenhouse; Wing Wai Yew; Jae-Joon Yim
Journal:  PLoS Med       Date:  2012-08-28       Impact factor: 11.069

9.  Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients.

Authors:  Chawangwa Modongo; Jotam G Pasipanodya; Nicola M Zetola; Scott M Williams; Giorgio Sirugo; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

10.  Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study.

Authors:  Caroline Franck; James A Seddon; Anneke C Hesseling; H Simon Schaaf; Donald Skinner; Lucy Reynolds
Journal:  BMC Infect Dis       Date:  2014-08-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.